Recursion Pharmaceuticals Stock Options Expiring on 29th of August

RXRX Stock  USD 6.40  0.56  9.59%   

Recursion Pharmaceuticals Corporate Management

Najat KhanChief OfficerProfile
Christopher GibsonCEO CoFounderProfile
Kevin LeggatVice AccountingProfile
Janelle GordonVice OperationsProfile
Shafique MDInterim OfficerProfile
Lina NilssonSenior PlatformProfile

Additional Tools for Recursion Stock Analysis

When running Recursion Pharmaceuticals' price analysis, check to measure Recursion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recursion Pharmaceuticals is operating at the current time. Most of Recursion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recursion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recursion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recursion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.